Uterine Adenomyosis Treated by Linzagolix, an Oral Gonadotropin-Releasing Hormone Receptor Antagonist: A Pilot Study with a New ’Hit Hard First and then Maintain’ Regimen of Administration

Uterine Adenomyosis Treated by Linzagolix, an Oral Gonadotropin-Releasing Hormone Receptor Antagonist: A Pilot Study with a New ’Hit Hard First and then Maintain’ Regimen of Administration

(1) Background: The aim of the present pilot study was to study the effect of a new oral gonadotropin-releasing hormone antagonist on adenomyosis. (2) Methods: Eight premenopausal women, aged between 37 and 45 years, presenting with heavy menstrual bleeding, pelvic pain, and dysmenorrhea due to diff...

Full description

Bibliographic Details
Main Authors: Jacques Donnez, Olivier Donnez, Jean Tourniaire, Michel Brethous, Elke Bestel, Elizabeth Garner, Sébastien Charpentier, Andrew Humberstone, Ernest Loumaye
Format: Article
Language:English
Published: MDPI AG 2021-12-01
Series:Journal of Clinical Medicine
Subjects:
adenomyosis
treatment
GnRH antagonist
linzagolix
Online Access:https://www.mdpi.com/2077-0383/10/24/5794

Internet

https://www.mdpi.com/2077-0383/10/24/5794

Similar Items